Your browser doesn't support javascript.
loading
Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification.
Sun, Dantong; Tao, Junyan; Yan, Weihua; Zhu, Jingjuan; Zhou, Hai; Sheng, Yingying; Xue, Chaofan; Li, Hong; Hou, Helei.
Afiliação
  • Sun D; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Tao J; Precision Medicine Center of Oncology, 235960The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Yan W; 235960Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Zhu J; Precision Medicine Center of Oncology, 235960The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Zhou H; Precision Medicine Center of Oncology, 235960The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Sheng Y; Medical College of Qingdao University, Qingdao, Shandong, China.
  • Xue C; Department of Oncology, The People's Hospital of Huangdao District, Qingdao, China.
  • Li H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Hou H; Precision Medicine Center of Oncology, 235960The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Technol Cancer Res Treat ; 21: 15330338221128414, 2022.
Article em En | MEDLINE | ID: mdl-36148917

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article